Alliance Pharma plc announced its plans for Board evolution. Alliance has transitioned from a Prescription Medicines business to a fast growth Consumer Healthcare company over recent years, with Consumer Healthcare revenues representing 75% of Group revenues in 2023. Over the last five years, Jo LeCouilliard has been instrumental in driving this transition, first as a Non-Executive Director and, more recently, as Chair.

Under her leadership, the Company has strengthened the Board, appointing two new directors with Consumer experience, particularly in the APAC region. Jo and the Board feel that it is now appropriate for her to step down from the Board and to appoint a new Chair, with strong international Consumer Healthcare experience, to lead the Company through its next strategic phase, focusing on organic growth through marketing and innovation. The Board also announced that Camillo Pane will be appointed to the Board and assume the role of Chair on 19 February 2024 following a handover period from Jo.

Camillo has over thirty years' experience in US, European and Asian public, multinational Consumer companies. During his career, Camillo has held a number of senior positions at Reckitt Benckiser where he spent almost 20 years across both Global and Regional roles, including Senior Vice President and Global Category Officer for Consumer Health, before moving to Coty Inc, one of the largest beauty companies in the world, where, as CEO, he led the merger with Procter & Gamble Specialty Beauty. Most recently, he was Group CEO of Health & Happiness Group, a global Health and Nutrition company listed on the Hong Kong Stock Exchange with revenues of around $2 billion.

Camillo Pane (aged 53 years) holds/has held the following directorships/partnerships in the last five years: Current directorships/partnerships: VCP & Partners Limited; LSG Hydra Limited and Passione Beauty s.p.a. Previous directorships/partnerships (last five years): Ocean Labs Beauty Ltd; Loum Holdings Ltd; Present Life Ltd. and Kadenwood Inc.